India · Delayed Price · Currency is INR Symbiotec Pharmalab Statistics
Total Valuation
NSE:SYMBIOTEC has a market cap or net worth of INR 76.98 billion. The enterprise value is 80.79 billion.
| Market Cap | 76.98B |
| Enterprise Value | 80.79B |
Important Dates
The last earnings date was Monday, September 21, 2026.
| Earnings Date | Sep 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:SYMBIOTEC has 64.26 million shares outstanding. The number of shares has increased by 12.70% in one year.
| Current Share Class | 64.26M |
| Shares Outstanding | 64.26M |
| Shares Change (YoY) | +12.70% |
| Shares Change (QoQ) | +14.07% |
| Owned by Insiders (%) | 12.93% |
| Owned by Institutions (%) | 42.39% |
| Float | 25.98M |
Valuation Ratios
The trailing PE ratio is 79.95.
| PE Ratio | 79.95 |
| Forward PE | n/a |
| PS Ratio | 8.71 |
| PB Ratio | 6.70 |
| P/TBV Ratio | 6.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 44.09 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 85.92 |
| EV / Sales | 9.14 |
| EV / EBITDA | 36.87 |
| EV / EBIT | 49.54 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 1.78 |
| Debt / FCF | -7.65 |
| Interest Coverage | 6.54 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.95% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 4.62M |
| Profits Per Employee | 490,966 |
| Employee Count | 1,915 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:SYMBIOTEC has paid 320.29 million in taxes.
| Income Tax | 320.29M |
| Effective Tax Rate | 25.41% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 68.10 |
| Average Volume (20 Days) | 1,727,949 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:SYMBIOTEC had revenue of INR 8.84 billion and earned 940.20 million in profits. Earnings per share was 14.98.
| Revenue | 8.84B |
| Gross Profit | 5.42B |
| Operating Income | 1.63B |
| Pretax Income | 1.26B |
| Net Income | 940.20M |
| EBITDA | 2.18B |
| EBIT | 1.63B |
| Earnings Per Share (EPS) | 14.98 |
Balance Sheet
The company has 101.25 million in cash and 3.91 billion in debt, with a net cash position of -3.81 billion or -59.27 per share.
| Cash & Cash Equivalents | 101.25M |
| Total Debt | 3.91B |
| Net Cash | -3.81B |
| Net Cash Per Share | -59.27 |
| Equity (Book Value) | 11.50B |
| Book Value Per Share | 183.27 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 1.75 billion and capital expenditures -2.26 billion, giving a free cash flow of -511.26 million.
| Operating Cash Flow | 1.75B |
| Capital Expenditures | -2.26B |
| Depreciation & Amortization | 546.98M |
| Net Borrowing | -1.56B |
| Free Cash Flow | -511.26M |
| FCF Per Share | -7.96 |
Margins
Gross margin is 61.26%, with operating and profit margins of 18.44% and 10.63%.
| Gross Margin | 61.26% |
| Operating Margin | 18.44% |
| Pretax Margin | 14.26% |
| Profit Margin | 10.63% |
| EBITDA Margin | 24.63% |
| EBIT Margin | 18.44% |
| FCF Margin | n/a |
Dividends & Yields
NSE:SYMBIOTEC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -12.70% |
| Shareholder Yield | -12.70% |
| Earnings Yield | 1.22% |
| FCF Yield | -0.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |